Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
October 25, 2023 at 08:00 am
Share
Fukuda Denshi Co., Ltd. revised consolidated earnings guidance for the fiscal year ending March 31, 2024. for the year, the company expects Net sales of JPY 130,000 million against JPY 130,000 million expected previously, Operating profit of JPY 23,000 million against JPY 20,000 million a year ago. Profit attributable to owners of parent of JPY 16,000 million against JPY 14,000 million and Earnings per share of JPY 528.91 against JPY 462.82 expected previously.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.